دورية أكاديمية
Mid-Term Results of Minimally Invasive Direct Coronary Artery Bypass Grafting
| العنوان: | Mid-Term Results of Minimally Invasive Direct Coronary Artery Bypass Grafting |
|---|---|
| المؤلفون: | Dong Hyun Seo, Jun Sung Kim, Kay-Hyun Park, Cheong Lim, Su Ryeun Chung, Dong Jung Kim |
| المصدر: | Korean Journal of Thoracic and Cardiovascular Surgery, Vol 51, Iss 1, Pp 8-14 (2018) |
| بيانات النشر: | Korean Society for Thoracic and Cardiovascular Surgery, 2018. |
| سنة النشر: | 2018 |
| المجموعة: | LCC:Surgery |
| مصطلحات موضوعية: | Coronary artery disease, Coronary artery bypass, Minimally invasive surgery, Surgery, RD1-811 |
| الوصف: | Background: Minimally invasive direct coronary artery bypass grafting (MIDCAB) has the advantage of allowing arterial grafting on the left anterior descending artery without a sternotomy incision. We present our single-center clinical experience of 66 consecutive patients. Methods: All patients underwent MIDCAB through a left anterior small thoracotomy between August 2007 and July 2015. Preoperative, intraoperative, postoperative and follow-up data—including major adverse cardiovascular and cerebrovascular events (MACCE), graft patency, and the need for re-intervention—were collected. Results: The mean age of the patients was 69.4±11.1 years and 73% were male. There was no conversion to an on-pump procedure or a sternotomy incision. The 30-day mortality rate was 1.5%. There were no cases of stroke, although 2 patients had to be re-explored for bleeding, and 81.8% were extubated in the operating room or on the day of surgery. The median stay in t he i ntensive c are u nit and in t he h ospital were 1 .5 a nd 9.6 days, respectively. The median follow-up period was 11 months, with a 5-year overall survival rate of 85.3%±0.09% and a 5-year MACCE-free survival rate of 72.8%±0.1%. Of the 66 patients, 32 patients with 36 grafts underwent a postoperative graft patency study with computed tomography angiography or coronary angiography, and 88.9% of the grafts were patent at 9.7±10.8 months postoperatively. Conclusion: MIDCAB is a safe procedure with low postoperative morbidity and mortality and favorable mid-term MACCE-free survival. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English Korean |
| تدمد: | 2093-6516 2233-601X |
| Relation: | http://www.kjtcvs.org/journal/download_pdf.php?doi=10.5090/kjtcs.2018.51.1.8; https://doaj.org/toc/2093-6516; https://doaj.org/toc/2233-601X |
| DOI: | 10.5090/kjtcs.2018.51.1.8 |
| URL الوصول: | https://doaj.org/article/9b0340dedd2148d197553f1ef0c3b4a9 |
| رقم الأكسشن: | edsdoj.9b0340dedd2148d197553f1ef0c3b4a9 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 20936516 2233601X |
|---|---|
| DOI: | 10.5090/kjtcs.2018.51.1.8 |